Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome.
Human papillomavirus (HPV) was detected in 17 (16.0%) of 106 patients undergoing treatment for IVF. Human papillomavirus-positive women had a decreased pregnancy rate (4 of 17, 23.5%) as compared with HPV-negative women (51 of 89, 57.0%; P<.02).
Spandorfer
Steven D
SD
The Center for Reproductive Medicine and Infertility, The New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA. sdspando@med.cornell.edu
Bongiovanni
Anne Marie
AM
Fasioulotis
Sozos
S
Rosenwaks
Zev
Z
Ledger
William J
WJ
Witkin
Steven S
SS
D000328:Adult; D005260:Female; D005307:Fertilization in Vitro / Q000706:statistics & numerical data*; D006801:Humans; D007247:Infertility, Female / Q000453:epidemiology* / Q000628:therapy* / Q000821:virology; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000821:virology; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology*; D015995:Prevalence; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology